维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Heisig P"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Exploring Knowledge and Information Needs in Engineering from the Past and for the Future-results from a Survey 显示文摘	Heisig P Caldwell NHM Grebici K Clarkson PJ	2010	Design Studies2010，31，5：	1
2	Harmonization of knowledge management-comparing160 KM frameworks around the globe显示文摘	HEISIG P	2009	Journal of Knowledge Management2009，13，4：	1
3	Inhibitors of bacterial topoisomerases:mechanisms of action and resistance and clinical aspects显示文摘	Heisig P	2001	Planta Med2001，67，1：	1
4	Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli显示文摘	Heisig P	1996	Antimicrob Agents Chemothera1996，40，：	1
5	Clinically significant borderline resistance of sequential clinical isolates of Klebsiella pneumoniae显示文摘	Wagenlehner FM Heisig P Irtenkauf C	2003	Int J Antimicrob Agents2003，22，4：	1
6	Beta-lactamase expression in Yersinia enterocolitica biovars 1A,1B and 3显示文摘	Heisig P Wiedemann B	2000	J Med Microbiol2000，49，：	1
7	Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli 显示文摘	Heisig P	1996	Antimicrob Agents Chemother1996，40，4：	1
8	Skin bacteria after chlorhexidine exposure-is there a difference in response to human betaDefensin-3?显示文摘	Reichel M Heisig A Heisig P	2010	Eur J Clin Microbiol Infect Dis2010，29，6：	1
9	Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherochia coli 显示文摘	Heisig P Schedletzky H Falkenstein-Paul H	1993	Antimicrob Agents Chemother1993，37，：	1
10	Genetic evidence for a role of ParC mutations in development of high level fluoroquinolone resistance in Escherlchia coli显示文摘	Heisig P	1996	Antimicrob Agents Chemother1996，40，4：	1
11	Harmonisafion of knowledge management -comparing 160 KM frameworks around the globe 显示文摘	HEISIG P	2009	Journal of knowledge management2009，13，4：	1
12	Topoisomerase IV mutations in quinolo-ne-resistant salmonellae selected in vitro显示文摘	Hansen H Heisig P	2003	Microb Drug Resist2003，9，1：	1
13	Topoisomerase IV mutations in quinolone-resistant Salmonellae selected in vitro显示文摘	HANSEN H HEISIG P	2003	Microb Drug Resist2003，9，1：	1
14	Type Ⅱ topoisomerases - inhibitors, repair mechanisms and mutations 显示文摘	Heisig P	2009	Mutagenesis2009，24，6：	1
15	Aspects and resuhs of long-term stable deposition of Al2O3 with high rate pulsed reactive magnetron sputtering 显示文摘	Frach P Heisig U Gottfried C Walde H	1993	Surf Coat Technol1993，59，：	1
16	Topoisomerase IV mutations in quinolone resistant salmonellae selected in vitro 显示文摘	Hansen H Heisig P	2003	Mierob Drug Resist2003，9，：	1
17	Skin bacteria after chlorhexidine exposure-is there a difference in response to human beta-Defensin-3显示文摘	Reichel M Heisig A Heisig P		0，，06：	1
18	Topoisomerase IV muta- tions in quinolone-resistant salmonellae selected in vitro 显示文摘	HANSEN H HEISIG P	2003	Microb Drug Resist2003，9，1：	1
19	Genetic evidence for a role of parC mutation in development of high-level fluoroquinolone resistance in Escherichia coli显示文摘		1996	Antimicrob Agents Chemother1996，40，：	1
20	Harmonisation of knowledge management-comparing 160 KM frameworks around the globe显示文摘	HEISIG P	2009	Journal of knowledge Management2009，13，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示